These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 2951356

  • 1. The role of L3T4-positive T lymphocytes in the generation of anti-tumor immunity in the mouse.
    Yamamoto H, Takata M, Fujimoto S.
    Jpn J Cancer Res; 1987 Feb; 78(2):176-84. PubMed ID: 2951356
    [Abstract] [Full Text] [Related]

  • 2. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.
    Chou T, Shu S.
    J Immunol; 1987 Sep 15; 139(6):2103-9. PubMed ID: 2957448
    [Abstract] [Full Text] [Related]

  • 3. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
    Barker E, Mokyr MB.
    Cancer Res; 1988 Sep 01; 48(17):4834-42. PubMed ID: 3261626
    [Abstract] [Full Text] [Related]

  • 4. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA, Shu S, Chou T, Perry-Lalley D, Chang AE.
    J Immunol; 1988 Aug 01; 141(3):1047-53. PubMed ID: 3260908
    [Abstract] [Full Text] [Related]

  • 5. Phenotype of syngeneic tumor-specific cytotoxic T-lymphocytes and requirements for their in vitro generation from tumor-bearing host and immune spleens.
    Bear HD, Susskind BM, Close KA, Barrett SK.
    Cancer Res; 1988 Mar 15; 48(6):1422-7. PubMed ID: 2964266
    [Abstract] [Full Text] [Related]

  • 6. Phenotype analyses and cellular mechanisms of the pre-effector T-lymphocyte response to a progressive syngeneic murine sarcoma.
    Sakai K, Chang AE, Shu SY.
    Cancer Res; 1990 Jul 15; 50(14):4371-6. PubMed ID: 2114215
    [Abstract] [Full Text] [Related]

  • 7. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD, Heinzel FP, Shigekane VM, Fisher WL, Locksley RM.
    J Immunol; 1987 Aug 15; 139(4):1303-9. PubMed ID: 3112230
    [Abstract] [Full Text] [Related]

  • 8. In vitro differentiation of T-cells capable of mediating the regression of established syngeneic tumors in mice.
    Shu S, Chou T, Rosenberg SA.
    Cancer Res; 1987 Mar 01; 47(5):1354-60. PubMed ID: 3102046
    [Abstract] [Full Text] [Related]

  • 9. Immunoglobulin-dependent helper T cells: studies in the MOPC-315 system suggest a novel surface antigen phenotype.
    Rohrer JW, Kemp JD.
    J Immunol; 1986 Sep 15; 137(6):1786-92. PubMed ID: 2943802
    [Abstract] [Full Text] [Related]

  • 10. Antibodies to the L3T4 and Lyt-2 molecules interfere with antigen receptor-driven activation of cloned murine T cells.
    Moldwin RL, Havran WL, Nau GJ, Lancki DW, Kim DK, Fitch FW.
    J Immunol; 1987 Aug 01; 139(3):657-64. PubMed ID: 2955046
    [Abstract] [Full Text] [Related]

  • 11. T-cell immunity to murine Moloney sarcoma virus-induced tumours: L3T4+ T cells are necessary for resistance to primary sarcoma growth, but Lyt-2+ T cells are required for resistance to secondary tumour cell challenge.
    Bateman WJ, Jenkinson EJ, Owen JJ.
    Immunology; 1987 Jul 01; 61(3):317-20. PubMed ID: 2956180
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.
    Dialynas DP, Quan ZS, Wall KA, Pierres A, Quintáns J, Loken MR, Pierres M, Fitch FW.
    J Immunol; 1983 Nov 01; 131(5):2445-51. PubMed ID: 6415170
    [Abstract] [Full Text] [Related]

  • 13. Importance of Lyt 2+ T-cells in the curative effectiveness of a low dose of melphalan for mice bearing a large MOPC-315 tumor.
    Mokyr MB, Barker E, Weiskirch LM, Takesue BY, Pyle JM.
    Cancer Res; 1989 Aug 15; 49(16):4597-606. PubMed ID: 2568174
    [Abstract] [Full Text] [Related]

  • 14. Regulation of Ia+ reticulum cell sarcoma (RCS) growth in syngeneic SJL/J mice. I. Inhibition of tumor growth by passive administration of L3T4 monoclonal antibody before or after tumor inoculation.
    Ohnishi K, Bonavida B.
    J Immunol; 1987 Jun 15; 138(12):4524-9. PubMed ID: 2953807
    [Abstract] [Full Text] [Related]

  • 15. [Effects of adult thymectomy on the growth of 203-glioma in mice--analysis of T cell subpopulation in tumor immunology].
    Yamasaki T, Yamashita J, Handa H, Namba Y, Hanaoka M.
    No To Shinkei; 1982 Nov 15; 34(11):1067-75. PubMed ID: 6984337
    [Abstract] [Full Text] [Related]

  • 16. Regulatory role of T lymphocytes and NK cells in tumor allograft development.
    Sobotková E, Nouza K.
    Neoplasma; 1993 Nov 15; 40(2):75-80. PubMed ID: 8350958
    [Abstract] [Full Text] [Related]

  • 17. Induction of immune tolerance during administration of monoclonal antibody to L3T4 does not depend on depletion of L3T4+ cells.
    Carteron NL, Wofsy D, Seaman WE.
    J Immunol; 1988 Feb 01; 140(3):713-6. PubMed ID: 2448372
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of humoral immunity in vivo by monoclonal antibody to L3T4: studies with soluble antigens in intact mice.
    Wofsy D, Mayes DC, Woodcock J, Seaman WE.
    J Immunol; 1985 Sep 01; 135(3):1698-701. PubMed ID: 3160776
    [Abstract] [Full Text] [Related]

  • 19. The role of L3T4+ and Lyt-2+ T cells in the IgE response and immunity to Nippostrongylus brasiliensis.
    Katona IM, Urban JF, Finkelman FD.
    J Immunol; 1988 May 01; 140(9):3206-11. PubMed ID: 2966208
    [Abstract] [Full Text] [Related]

  • 20. Autoimmune syndrome after induction of neonatal tolerance to alloantigens: effects of in vivo treatment with anti-T cell subset monoclonal antibodies.
    Merino J, Schurmans S, Luzuy S, Izui S, Vassalli P, Lambert PH.
    J Immunol; 1987 Sep 01; 139(5):1426-31. PubMed ID: 3114366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.